Goldman Higher on Earnings; Apple Tariff Relieve; Pfizer Drug Pivot

On this episode of Stock Movers:
- Goldman Sachs (GS) shares are higher after reporting earnings. The big bank approved a $40 billion share buyback program and its 1Q equities trading revenue beat estimates.
- Apple (AAPL) is also higher with news of tech tariff exemptions. Needham analyst Laura Martin is also reiterating her Apple Buy position in addition to the news, maintaining her $225 price target.
- Pfizer (PFE) is down today as it plans to abandon its obesity pill, danuglipron, due to a potentially drug-related liver injury in a clinical trial patient. The company will instead invest in earlier-stage obesity treatments, a setback in its efforts to compete with Novo Nordisk and Eli Lilly in the weight-loss market.
- Intel (INTC) is soaring this morning as many chip-exposed companies are rising on news of a pause in US tariffs on chips and tech. Intel is also nearing an agreement to sell a stake in its programmable chips unit, Altera, to Silver Lake Management.

See omnystudio.com/listener for privacy information.